TipRanks
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market
MARKSANS
Marksans Pharma Limited
RESEARCH TOOLSreports
Want to see IN:MARKSANS full AI Analyst Report?

Marksans Pharma Limited (MARKSANS) Income Statement

8 Followers

Marksans Pharma Limited Income Statement

Last quarter (Q1 2027), Marksans Pharma Limited's total revenue was ₹8.41B, an increase of 35.61% from the same quarter last year. In Q1, Marksans Pharma Limited's net income was ₹1.57B. See Marksans Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 29.51B₹ 26.23B₹ 21.77B₹ 18.52B₹ 14.80B
Gross Profit
₹ 11.57B₹ 14.79B₹ 11.03B₹ 9.31B₹ 7.32B
Operating Expenses
₹ 6.52B₹ 3.50B₹ 3.29B₹ 2.68B₹ 5.15B
Depreciation and Amortization
₹ 986.32M₹ 833.86M₹ 742.70M₹ 518.53M₹ 447.76M
EBITDA
₹ 6.03B₹ 5.29B₹ 5.09B₹ 3.99B₹ 3.01B
Operating Income
₹ 5.05B₹ 11.29B₹ 3.87B₹ 3.00B₹ 5.17B
Other Income/Expenses
₹ 557.99M₹ -6.25B₹ 360.31M₹ 378.41M₹ -2.69B
Pretax Income
₹ 5.61B₹ 5.04B₹ 4.24B₹ 3.38B₹ 2.48B
Net Income
₹ 4.18B₹ 3.81B₹ 3.14B₹ 2.66B₹ 1.85B
Per Share Metrics
Basic EPS
₹ 9.22₹ 8.40₹ 6.92₹ 6.41₹ 4.51
Diluted EPS
₹ 9.22₹ 8.40₹ 6.92₹ 6.41₹ 4.51
Weighted Average Shares Outstanding
 453.25M 453.06M 453.16M 415.40M 409.31M
Weighted Average Shares Outstanding (Diluted)
 453.25M 453.06M 453.16M 415.40M 409.31M
Currency in INR

Marksans Pharma Limited Earnings and Revenue History